Tech Company Financing Transactions
Potenza Therapeutics Funding Round
Potenza Therapeutics secured a $15 million funding round on 3/31/2016. Investors included InterWest Partners, MPM Capital and private investors.
Transaction Overview
Company Name
Announced On
3/31/2016
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Undisclosed
Investors
InterWest Partners (Arnold Oronsky)
MPM Capital (Luke Evnin)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
700 Main St. North
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Potenza Therapeutics is focusing on the discovery and development of novel immune-oncology therapeutics: Molecules that stimulate the power of the immune system to fight cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Lisa Velardo
Co-Founder
Peter Parker
Controller
Abby Johnson
President
Johannes Fruehauf
VP - Operations
Krista Licata
VP - Operations
Maggie O'Toole
Browse more venture capital transactions:
Prev: 3/31/2016: Theatre Galleria venture capital transaction
Next: 3/31/2016: Applariat venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs